Hackensack Meridian Health
Clinical trials sponsored by Hackensack Meridian Health, explained in plain language.
-
New combo may Re-Sensitize Drug-Resistant myeloma
Disease control CompletedThis study tested whether adding a drug called vorinostat to the standard combination of lenalidomide and dexamethasone could help people with multiple myeloma whose cancer had stopped responding to lenalidomide. The trial enrolled 25 patients with relapsed or refractory myeloma.…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Apr 29, 2026 05:15 UTC
-
Experimental drug shows promise for rare blood cancer
Disease control CompletedThis study tested the drug carfilzomib in 7 people with Waldenström's macroglobulinemia, a rare blood cancer, that had come back after previous treatment. The goal was to see if the drug could shrink tumors and control the disease. Carfilzomib works by blocking a protein that cel…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Apr 29, 2026 05:14 UTC